These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 33229294)
1. Adherence with lipid screening guidelines in standard- and high-risk children and adolescents. Berger JH; Chen F; Faerber JA; O'Byrne ML; Brothers JA Am Heart J; 2021 Feb; 232():39-46. PubMed ID: 33229294 [TBL] [Abstract][Full Text] [Related]
2. Adherence With Lipid Screening Guidelines in Children With Acquired and Congenital Heart Disease: An Observational Study Using Data From The MarketScan Commercial and Medicaid Databases. Berger JH; Faerber JA; Chen F; Lin KY; Brothers JA; O'Byrne ML J Am Heart Assoc; 2022 Apr; 11(7):e024197. PubMed ID: 35301862 [TBL] [Abstract][Full Text] [Related]
3. Universal Lipid Screening in 9- to 11-Year-Olds Before and After 2011 Guidelines. Mihalopoulos NL; Stipelman C; Hemond J; Brown LL; Young PC Acad Pediatr; 2018 Mar; 18(2):196-199. PubMed ID: 29180296 [TBL] [Abstract][Full Text] [Related]
4. Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database. Brixner D; Ghate SR; McAdam-Marx C; Ben-Joseph R; Said Q J Manag Care Pharm; 2008 Oct; 14(8):756-67. PubMed ID: 18983205 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk stratification in primary care patients with arterial hypertension: Results from the Swiss Hypertension Cohort Study (HccH). Handschin A; Brighenti-Zogg S; Mundwiler J; Giezendanner S; Gregoriano C; Martina B; Tschudi P; Leuppi JD; Zeller A; Dieterle T Eur J Prev Cardiol; 2019 Nov; 26(17):1843-1851. PubMed ID: 31189378 [TBL] [Abstract][Full Text] [Related]
6. Impact of Primary Care Physician Interaction on Longitudinal Adherence to Screening Mammography Across Different Racial/Ethnic Groups. Flores EJ; López D; Miles RC; Glover M; Lehman CD; Harvey HB; Narayan AK J Am Coll Radiol; 2019 Jul; 16(7):908-914. PubMed ID: 30737162 [TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians. de Ferranti SD; Rodday AM; Parsons SK; Cull WL; O'Connor KG; Daniels SR; Leslie LK J Pediatr; 2017 Jun; 185():99-105.e2. PubMed ID: 28209292 [TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia Screening of 9- to 11-Year-Olds at Well-Child Visits by Utah Pediatricians. Stipelman C; Young PC; Hemond J; Brown LL; Mihalopoulos NL Clin Pediatr (Phila); 2017 Dec; 56(14):1286-1290. PubMed ID: 28006979 [TBL] [Abstract][Full Text] [Related]
13. Physicians' Lack of Adherence to National Heart, Lung, and Blood Institute Guidelines for Pediatric Lipid Screening. Valle CW; Binns HJ; Quadri-Sheriff M; Benuck I; Patel A Clin Pediatr (Phila); 2015 Oct; 54(12):1200-5. PubMed ID: 25813383 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of Children Referred to a Lipid Clinic Before and After the Universal Screening Guidelines. Selvaraj K; Olave-Pichon A; Benuck I; Ariza AJ; Binns HJ Clin Pediatr (Phila); 2019 Jun; 58(6):656-664. PubMed ID: 30854883 [TBL] [Abstract][Full Text] [Related]
15. Lipid screening in children and adolescents in community practice: 2007 to 2010. Margolis KL; Greenspan LC; Trower NK; Daley MF; Daniels SR; Lo JC; Kharbanda EO; Sinaiko AR; Magid DJ; Parker ED; Chandra M; Tavel HM; O'Connor PJ Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):718-26. PubMed ID: 25160839 [TBL] [Abstract][Full Text] [Related]
16. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Mitchell AJ; Delaffon V; Vancampfort D; Correll CU; De Hert M Psychol Med; 2012 Jan; 42(1):125-47. PubMed ID: 21846426 [TBL] [Abstract][Full Text] [Related]
17. Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study. Scuteri A; Najjar SS; Orru' M; Albai G; Strait J; Tarasov KV; Piras MG; Cao A; Schlessinger D; Uda M; Lakatta EG Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):532-41. PubMed ID: 19321325 [TBL] [Abstract][Full Text] [Related]
18. Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance. Moeller KE; Rigler SK; Mayorga A; Nazir N; Shireman TI Schizophr Res; 2011 Mar; 126(1-3):117-23. PubMed ID: 21168994 [TBL] [Abstract][Full Text] [Related]
19. Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients. Chanchlani R; Joseph Kim S; Kim ED; Banh T; Borges K; Vasilevska-Ristovska J; Li Y; Ng V; Dipchand AI; Solomon M; Hebert D; Parekh RS Nephrol Dial Transplant; 2017 Sep; 32(9):1579-1586. PubMed ID: 29059403 [TBL] [Abstract][Full Text] [Related]